200 related articles for article (PubMed ID: 36238249)
1. Rhein inhibits
Yu X; Xu Q; Chen W; Mai Z; Mo L; Su X; Ou J; Lan Y; Zheng H; Xue Y
Front Public Health; 2022; 10():1002029. PubMed ID: 36238249
[TBL] [Abstract][Full Text] [Related]
2. Interventions for treating genital Chlamydia trachomatis infection in pregnancy.
Cluver C; Novikova N; Eriksson DO; Bengtsson K; Lingman GK
Cochrane Database Syst Rev; 2017 Sep; 9(9):CD010485. PubMed ID: 28937705
[TBL] [Abstract][Full Text] [Related]
3. Mass drug administration of azithromycin for trachoma reduces the prevalence of genital Chlamydia trachomatis infection in the Solomon Islands.
Marks M; Bottomley C; Tome H; Pitakaka R; Butcher R; Sokana O; Kako H; Solomon AW; Mabey DC
Sex Transm Infect; 2016 Jun; 92(4):261-5. PubMed ID: 26888658
[TBL] [Abstract][Full Text] [Related]
4. Azithromycin treatment modulates the extracellular signal-regulated kinase mediated pathway and inhibits inflammatory cytokines and chemokines in epithelial cells from infertile women with recurrent Chlamydia trachomatis infection.
Srivastava P; Vardhan H; Bhengraj AR; Jha R; Singh LC; Salhan S; Mittal A
DNA Cell Biol; 2011 Aug; 30(8):545-54. PubMed ID: 21438755
[TBL] [Abstract][Full Text] [Related]
5. Activities of first-choice antimicrobials against gamma interferon-treated Chlamydia trachomatis differ in hypoxia.
Shima K; Klinger M; Solbach W; Rupp J
Antimicrob Agents Chemother; 2013 Jun; 57(6):2828-30. PubMed ID: 23478971
[TBL] [Abstract][Full Text] [Related]
6. An in vitro model of azithromycin-induced persistent Chlamydia trachomatis infection.
Xue Y; Zheng H; Mai Z; Qin X; Chen W; Huang T; Chen D; Zheng L
FEMS Microbiol Lett; 2017 Aug; 364(14):. PubMed ID: 28854672
[TBL] [Abstract][Full Text] [Related]
7. High treatment failure rate is better explained by resistance gene detection than by minimum inhibitory concentration in patients with urogenital Chlamydia trachomatis infection.
Shao L; You C; Cao J; Jiang Y; Liu Y; Liu Q
Int J Infect Dis; 2020 Jul; 96():121-127. PubMed ID: 32173573
[TBL] [Abstract][Full Text] [Related]
8. Differing effects of azithromycin and doxycycline on cytokines in cells from Chlamydia trachomatis-infected women.
Srivastava P; Bhengraj AR; Jha HC; Vardhan H; Jha R; Singh LC; Salhan S; Mittal A
DNA Cell Biol; 2012 Mar; 31(3):392-401. PubMed ID: 21848430
[TBL] [Abstract][Full Text] [Related]
9. PAMAM dendrimer-azithromycin conjugate nanodevices for the treatment of Chlamydia trachomatis infections.
Mishra MK; Kotta K; Hali M; Wykes S; Gerard HC; Hudson AP; Whittum-Hudson JA; Kannan RM
Nanomedicine; 2011 Dec; 7(6):935-44. PubMed ID: 21658474
[TBL] [Abstract][Full Text] [Related]
10.
Seleem MA; Wood NA; Brinkworth AJ; Manam S; Carabeo RA; Murthy AK; Ouellette SP; Conda-Sheridan M
ACS Infect Dis; 2022 Jan; 8(1):227-241. PubMed ID: 34935346
[No Abstract] [Full Text] [Related]
11. Azithromycin treatment follow-up: antibacterial susceptibility of Chlamydia trachomatis in patients with chronic prostatitis.
Smelov V; Krylova T; Smelova N; Norman L
Int J Antimicrob Agents; 2004 Mar; 23 Suppl 1():S79-82. PubMed ID: 15037332
[TBL] [Abstract][Full Text] [Related]
12. [Infections with Chlamydia trachomatis].
Stock I; Henrichfreise B
Med Monatsschr Pharm; 2012 Jun; 35(6):209-22; quiz 223-4. PubMed ID: 22808665
[TBL] [Abstract][Full Text] [Related]
13. Association of the in vitro susceptibility of clinical isolates of chlamydia trachomatis with serovar and duration of antibiotic exposure.
Zheng H; Xue Y; Bai S; Qin X; Lu P; Yang B
Sex Transm Dis; 2015 Mar; 42(3):115-9. PubMed ID: 25668641
[TBL] [Abstract][Full Text] [Related]
14. An optimized, fast-to-perform mouse lung infection model with the human pathogen Chlamydia trachomatis for in vivo screening of antibiotics, vaccine candidates and modified host-pathogen interactions.
Dutow P; Wask L; Bothe M; Fehlhaber B; Laudeley R; Rheinheimer C; Yang Z; Zhong G; Glage S; Klos A
Pathog Dis; 2016 Mar; 74(2):. PubMed ID: 26676260
[TBL] [Abstract][Full Text] [Related]
15. Macrolide and fluoroquinolone resistance is uncommon in clinical strains of Chlamydia trachomatis.
Deguchi T; Hatazaki K; Ito S; Kondo H; Horie K; Nakane K; Mizutani K; Tsuchiya T; Yasuda M; Yokoi S; Nakano M
J Infect Chemother; 2018 Aug; 24(8):610-614. PubMed ID: 29627327
[TBL] [Abstract][Full Text] [Related]
16. Which treatment for genital tract Chlamydia trachomatis infection?
Tobin JM; Harindra V; Mani R
Int J STD AIDS; 2004 Nov; 15(11):737-9. PubMed ID: 15537459
[TBL] [Abstract][Full Text] [Related]
17. Azithromycin in the management of Chlamydia trachomatis infections.
Ridgway GL
Int J STD AIDS; 1996; 7 Suppl 1():5-8. PubMed ID: 8652727
[TBL] [Abstract][Full Text] [Related]
18. Nonoptimal Vaginal Microbiota After Azithromycin Treatment for Chlamydia trachomatis Infection.
Tamarelle J; Ma B; Gajer P; Humphrys MS; Terplan M; Mark KS; Thiébaut ACM; Forney LJ; Brotman RM; Delarocque-Astagneau E; Bavoil PM; Ravel J
J Infect Dis; 2020 Feb; 221(4):627-635. PubMed ID: 31573603
[TBL] [Abstract][Full Text] [Related]
19. Randomized, open-label, multicenter study of azithromycin compared with doxycycline for treating anorectal Chlamydia trachomatis infection concomitant to a vaginal infection (CHLAZIDOXY study).
Peuchant O; Lhomme E; Krêt M; Ghezzoul B; Roussillon C; Bébéar C; Perry F; de Barbeyrac B;
Medicine (Baltimore); 2019 Feb; 98(7):e14572. PubMed ID: 30762806
[TBL] [Abstract][Full Text] [Related]
20. Effects of azithromycin and rifampin on Chlamydia trachomatis infection in vitro.
Dreses-Werringloer U; Padubrin I; Zeidler H; Köhler L
Antimicrob Agents Chemother; 2001 Nov; 45(11):3001-8. PubMed ID: 11600348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
